(Q34656958)

3 August 2017

1 reference

title

Clinical studies on alclofenac in the treatment of rheumatic diseases: a drug in question (English)

1 reference

3 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

M. Aylward

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A241597

27 January 2023

language of work or name

English

0 references

publication date

1 January 1975

1 reference

full work available at URL

3 August 2017

http://www.tandfonline.com/doi/pdf/10.1185/03007997509114778

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Current Medical Research and Opinion

27 January 2023

published in

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

274-285

1 reference

A review of possible mechanisms of action of the antirheumatic drug, alclofenac

3 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Total and free-plasma tryptophan concentrations in rheumatoid disease

27 January 2023

4

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor

27 January 2023

5

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis

27 January 2023

6

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis

27 January 2023

7

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Double-blind comparison of alclofenac and aspirin in the treatment of rheumatoid arthritis. Part II: high dosage regime for assessment of analgesic and anti-inflammatory activity

27 January 2023

8

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Generalization from pain of various types and diverse origins

27 January 2023

9

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

27 January 2023

10

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

4-Allyloxy-3-chlorophenylacetic acid, a new type of analgesic, antipyretic and antiphlogistic drug

27 January 2023

11

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis

27 January 2023

12

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

27 January 2023

14

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Penicillamine in rheumatoid disease: a long-term study

27 January 2023

15

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects

27 January 2023

18

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

EMPIRE Rheumatism Council; multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results up to one year

27 January 2023

19

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Sterility and testicular atrophy related to cyclophosphamide therapy

27 January 2023

20

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

27 January 2023

21

205

597

Hart F. D.

1970

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Adverse reactions to alclofenac

27 January 2023

22

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

A double-blind, between-patient comparison of alclofenac ('Prinalgin') and indomethacin in the treatment of low back pain and sciatica

27 January 2023

23

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Cyclophosphamide and reproductive function.

27 January 2023

25

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis

27 January 2023

27

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Letter: Adverse reactions to alclofenac.

27 January 2023

28

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

The effect of sodium salicylate on the binding of L-tryptophan to serum proteins

27 January 2023

29

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. A second report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other t

27 January 2023

33

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis

27 January 2023

35

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

Simultaneous pharmacokinetics of alclofenac in plasma and synovial fluid in patients with rheumatoid arthritis

27 January 2023

37

1 reference

https://api.crossref.org/works/10.1185/03007997509114778

27 January 2023

Identifiers

1 reference

3 August 2017

1 reference